Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension

Author(s):  Allen Loyd V Jr

Issue:  Jan/Feb 2018 - Volume 22, Number 1
View All Articles in Issue

Page(s):  55

Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension Page 1

Download in electronic PDF format for $75

Abstract:  A formulation for preparing Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, penicillamine-D, chelating agent, heavy metals, rheumatoid arthritis, cystinuria, primary biliary cirrhosis, scleroderma, Wilson disease, copper poisoning, lead poisoning

Related Categories: EXCIPIENTS, FORMULATIONS, GASTROENTEROLOGY, ALLERGY/IMMUNOLOGY/INFLAMMATION

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Jan/Feb 2018
Pg. 55

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions
Polonini HC
, Loures S, Lima LC, Ferreira AO, Brandão MA
Mar/Apr 2016
Pg. 167-174

Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension
Allen Loyd V Jr
Nov/Dec 2019
Pg. 493

Basics of Compounding for Cough
Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312

Levofloxacin 50 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Sep/Oct 2020
Pg. 407

Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 412

Sulfasalazine 100 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2019
Pg. 490

Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents
Allen Loyd V Jr
Jan/Feb 2020
Pg. 38-43

Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Jan/Feb 2020
Pg. 60

Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Mar/Apr 2022
Pg. 140

Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jan/Feb 2021
Pg. 46

Acetaminophen (Paracetamol) 50 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jan/Feb 2021
Pg. 42

Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 503

Pyridoxine Hydrochloride 50 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2022
Pg. 149

Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
Nov/Dec 2019
Pg. 486

Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2018
Pg. 494

Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2017
Pg. 491

Return to Top